Home › Longkanker › Connecticut › Stamford
Longkanker klinische studies in Stamford, CT
10 studies voor Longkanker zoeken deelnemers op locaties in en rond Stamford (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekruterenFase 3
- Stamford Hospital/Bennett Cancer Center, Stamford
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mijl verwijderd
- Good Samaritan University Hospital, West Islip · 27 mijl verwijderd
- Northwell Health Imbert Cancer Center, Bay Shore · 27 mijl verwijderd
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruterenFase 3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Stamford Hospital/Bennett Cancer Center, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mijl verwijderd
- en nog 1
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RekruterenFase 3
- Stamford Hospital ( Site 0083), Stamford
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruterenFase 3
- Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mijl verwijderd
- Northwell Health Imbert Cancer Center, Bay Shore · 27 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mijl verwijderd
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mijl verwijderd
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Smilow Cancer Hospital Care Center at Long Ridge, Stamford
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mijl verwijderd
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RekruterenObservatieonderzoek
- Stamford Hospital, Stamford
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RekruterenObservatieonderzoek
- The Stamford Health/The Stamford Hospital, Stamford
- Good Samaritan Cancer Center, West Islip · 27 mijl verwijderd
Longkanker studies in andere steden
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Baltimore, MD40 studies
- Nashville, TN40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Andere studies in Stamford
- Borstkanker9 studies
- Niet-kleincellige longkanker8 studies
- Migraine6 studies
- Obesitas6 studies
- Prostaatkanker5 studies
- Eierstokkanker5 studies
- Aldermeesklierkanker4 studies
- Cardiovasculaire ziekte4 studies
- Overgewicht4 studies
- Metastatische kanker3 studies
- Neurologische aandoeningen3 studies
- Hartfalen3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.